Cape Bio Pharms is a pioneering brand in Cape Town, South Africa, specializing in plant-molecular pharming of recombinant proteins. As a leading player in the field, they offer a wide range of products and services. Their ISO 13485 certified production subsidiaries provide high-quality recombinant proteins, including monoclonal antibodies, proteins, and enzymes, at affordable prices for customers worldwide.

These proteins can be used as research or diagnostic reagents, and can even be developed into therapeutic or vaccine candidates under GMP compliance regulations. What sets Cape Bio Pharms apart is their unique transient plant-based expression technology, which offers distinct advantages over traditional expression systems. With its headquarters in Cape Town, the brand drives innovation by conducting product and process research, as well as owning and developing the group's intellectual property.

With a focus on affordability and collaboration, Cape Bio Pharms is making a significant impact in the biotech industry. For more information about their industry-leading technology and wide range of products, visit their website